US News

Exclusive: European efforts to assess Russia’s Sputnik V vaccine stymied by data gaps

Published by

By Michel Rose, Polina Ivanova and Emilio Parodi PARIS (Reuters) – The developers of Russia’s Sputnik V coronavirus vaccine have repeatedly failed to provide data that regulators deem to be standard requirements of the drug approval process, according to five people with knowledge of European efforts to assess the drug, providing new insight into the country’s struggle to win foreign acceptance of its product. Reuters reported last month that the European Medicines Agency (EMA)’s review of the drug’s safety and efficacy was delayed because a June 10 deadline to submit data on the vaccine’s cli…

Read More

Facebook Comments

Check Also

Australia’s east coast battles rising COVID-19 cases

Published by Reuters By Lidia Kelly MELBOURNE (Reuters) ...